1. Home
  2. ZEO vs CGTX Comparison

ZEO vs CGTX Comparison

Compare ZEO & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEO
  • CGTX
  • Stock Information
  • Founded
  • ZEO 2005
  • CGTX 2007
  • Country
  • ZEO United States
  • CGTX United States
  • Employees
  • ZEO N/A
  • CGTX N/A
  • Industry
  • ZEO
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEO
  • CGTX Health Care
  • Exchange
  • ZEO NYSE
  • CGTX Nasdaq
  • Market Cap
  • ZEO 31.6M
  • CGTX 30.0M
  • IPO Year
  • ZEO N/A
  • CGTX 2021
  • Fundamental
  • Price
  • ZEO $2.52
  • CGTX $0.64
  • Analyst Decision
  • ZEO
  • CGTX Strong Buy
  • Analyst Count
  • ZEO 0
  • CGTX 6
  • Target Price
  • ZEO N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • ZEO 1.8M
  • CGTX 891.3K
  • Earning Date
  • ZEO 03-18-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • ZEO N/A
  • CGTX N/A
  • EPS Growth
  • ZEO N/A
  • CGTX N/A
  • EPS
  • ZEO N/A
  • CGTX N/A
  • Revenue
  • ZEO $77,582,314.00
  • CGTX N/A
  • Revenue This Year
  • ZEO N/A
  • CGTX N/A
  • Revenue Next Year
  • ZEO N/A
  • CGTX N/A
  • P/E Ratio
  • ZEO N/A
  • CGTX N/A
  • Revenue Growth
  • ZEO N/A
  • CGTX N/A
  • 52 Week Low
  • ZEO $1.05
  • CGTX $0.34
  • 52 Week High
  • ZEO $11.60
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • ZEO 50.46
  • CGTX 43.76
  • Support Level
  • ZEO $2.31
  • CGTX $0.60
  • Resistance Level
  • ZEO $2.86
  • CGTX $0.82
  • Average True Range (ATR)
  • ZEO 0.42
  • CGTX 0.06
  • MACD
  • ZEO -0.04
  • CGTX -0.02
  • Stochastic Oscillator
  • ZEO 26.26
  • CGTX 18.56

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: